Travis Steed

Q: What is Travis Steed's success rate?

Travis Steed currently has a success rate of 92.51222681899799.

Q: What is the average return of Travis Steed's calls?

Their stock ratings have generated an average return of 27.340658830831167.

B of A Securities | Healthcare

Travis Steed is an analyst from B of A Securities specializing in the Healthcare sector. Ranked #673 out of 4773 analysts, they have issued 18 stock ratings with a success rate of 92.51% and an average return of 27.34%.

With 18 ratings to date, Travis Steed is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 92.51% and an average return of 27.34%, highlighting promising potential as their track record develops further.

#673

Out of 4773

Total Ratings

+92.51%

Success Rate

+27.34%

Average Return

Recent Ratings Analysis

CNMD

Sell

Jun 29, 2026

Target

$40.00

Current

$46.22

Performance

34.32%

Travis Steed rated CNMD as Underperform on Jun 29, 2026, setting a price target of 40. The bearish call was validated, as shares fell 34.32% to 46.22.

MOBI

Buy

Jun 02, 2026

Target

$16.00

Current

$10.25

Performance

—

On Jun 02, 2026, MOBI was given a Buy rating by Travis Steed, with a target price of 16. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

DXCM

Buy

May 18, 2026

Target

$80.00

Current

$84.51

Performance

29.84%

DXCM received a Buy rating from Travis Steed on May 18, 2026, aiming for 80. Momentum has favored the Buy call, with shares climbing from 84.51 to 84.51, rewarding those who trusted the recommendation.

BBNX

Hold

May 18, 2026

Target

$11.00

Current

$16.59

Performance

76.49%

On May 18, 2026, Travis Steed published a Neutral outlook on BBNX, with a target of 11. The Hold call missed some of the bullish momentum as shares advanced toward 11.

EMBC

Sell

May 18, 2026

Target

$3.00

Current

$4.89

Performance

61.39%

Travis Steed on May 18, 2026 assigned EMBC a Underperform rating, with a price target of 3. The market validated the bearish call with a pullback to 4.89.

ISRG

Buy

May 18, 2026

Target

$520.00

Current

$360.46

Performance

-18.06%

On May 18, 2026, Travis Steed reaffirmed ISRG with a Buy rating, targeting 520. Shares slid 18.06% despite the recommendation, highlighting downside risks.

MMED

Buy

May 18, 2026

Target

$20.00

Current

$22.44

Performance

106.25%

MMED was rated Buy by Travis Steed on May 18, 2026, with a price objective of 20. A bullish response from the market helped close the gap of -2.44 to the target.

PODD

Buy

May 18, 2026

Target

$208.00

Current

$134.68

Performance

-11.68%

On May 18, 2026, Travis Steed initiated coverage on PODD with a Buy rating and target of 208. The Buy call has yet to be validated as shares remain 73.32 away from the target.

TNDM

Hold

May 18, 2026

Target

$25.00

Current

$18.31

Performance

35.33%

Travis Steed issued a Neutral recommendation for TNDM on May 18, 2026, price target set at 25. A neutral call gave way to stronger-than-expected performance, closing in on 25.

ABT

Buy

Apr 17, 2026

Target

$120.00

Current

$103.37

Performance

6.78%

On Apr 17, 2026, ABT was evaluated by Travis Steed, who gave a Buy rating and target of 120. This case illustrates how a timely bullish rating can translate into tangible gains of 6.78%.

BDX

Hold

Jan 05, 2026

Target

$207.00

Current

$176.42

Performance

-11.33%

Travis Steed rated BDX as Neutral on Jan 05, 2026, setting a price target of 207. The cautious Hold call aligned with subsequent weakness, as shares slipped 11.33%.

PEN

Buy

Jan 05, 2026

Target

$370.00

Current

$317.78

Performance

0.88%

On Jan 05, 2026, PEN was given a Buy rating by Travis Steed, with a target price of 370. The stock traded sideways with a 0.88% move, keeping the bullish thesis unresolved.

MASI

Hold

Nov 17, 2025

Target

$162.00

Current

$179.95

Performance

22.39%

MASI received a Neutral rating from Travis Steed on Nov 17, 2025, aiming for 162. Investors saw gains of 22.39% that the cautious stance didn’t fully capture.

SOLV

Hold

Feb 26, 2025

Target

$85.00

Current

$87.65

Performance

4.30%

On Feb 26, 2025, Travis Steed published a Neutral outlook on SOLV, with a target of 85. Sideways action left the Hold view intact, with no major move since 87.65.

EW

Buy

Dec 16, 2024

Target

$90.00

Current

$86.77

Performance

17.40%

Travis Steed on Dec 16, 2024 assigned EW a Buy rating, with a price target of 90. The Buy call aligned well with market performance, producing a gain of 17.40%.

Frequency Asked Questions

Who is Travis Steed?

Travis Steed is an analyst from B of A Securities specializing in the Healthcare sector.

What is Travis Steed's success rate?

Travis Steed currently has a success rate of +92.51%.

How many ratings has Travis Steed issued?

Travis Steed has issued 18 stock ratings so far.

What is the average return of Travis Steed's calls?

Their stock ratings have generated an average return of +27.34%.

What is Travis Steed's ranking?

Travis Steed is ranked #673 out of 4773 analysts.

What types of ratings does Travis Steed give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Travis Steed?

You can follow Travis Steed by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Travis Steed?

Their latest rating was a Sell on CNMD issued on 2026-06-29.